SG Americas Securities’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.2M Buy
258,461
+240,283
+1,322% +$16.4M 0.01% 592
2026
Q1
$1.18M Sell
18,178
-16,915
-48% -$1.19M ﹤0.01% 1659
2025
Q4
$2.36M Buy
35,093
+9,260
+36% +$623K ﹤0.01% 1430
2025
Q3
$1.9M Sell
25,833
-6,879
-21% -$457K 0.01% 979
2025
Q2
$1.7M Buy
32,712
+5,871
+22% +$334K 0.01% 851
2025
Q1
$1.71M Buy
26,841
+14,475
+117% +$841K 0.01% 858
2024
Q4
$591K Buy
12,366
+180
+1% +$9.23K ﹤0.01% 1189
2024
Q3
$698K Buy
12,186
+9,569
+366% +$549K ﹤0.01% 1391
2024
Q2
$137K Sell
2,617
-20,750
-89% -$910K ﹤0.01% 2373
2024
Q1
$951K Buy
23,367
+18,043
+339% +$676K ﹤0.01% 1151
2023
Q4
$197K Sell
5,324
-42,340
-89% -$1.59M ﹤0.01% 2182
2023
Q3
$1.82M Buy
47,664
+44,019
+1,208% +$1.8M 0.02% 804
2023
Q2
$131K Sell
3,645
-42,185
-92% -$1.44M ﹤0.01% 1972
2023
Q1
$1.75M Sell
45,830
-4,102
-8% -$192K 0.02% 745
2022
Q4
$2.84M Sell
49,932
-16,301
-25% -$835K 0.03% 428
2022
Q3
$2.62M Buy
66,233
+36,809
+125% +$1.63M 0.03% 473
2022
Q2
$1.29M Sell
29,424
-37,038
-56% -$1.6M 0.01% 1077
2022
Q1
$2.65M Sell
66,462
-25,599
-28% -$912K 0.02% 722
2021
Q4
$3.7M Buy
92,061
+38,645
+72% +$1.44M 0.02% 641
2021
Q3
$2.17M Buy
53,416
+26,078
+95% +$1.09M 0.01% 1194
2021
Q2
$1.24M Sell
27,338
-3,187
-10% -$141K 0.01% 1420
2021
Q1
$1.27M Buy
30,525
+9,757
+47% +$445K 0.01% 1354
2020
Q4
$887K Sell
20,768
-2,241
-10% -$80.6K ﹤0.01% 1603
2020
Q3
$605K Sell
23,009
-56,452
-71% -$1.57M ﹤0.01% 1509
2020
Q2
$2.13M Sell
79,461
-14,459
-15% -$326K 0.02% 791
2020
Q1
$1.69M Buy
93,920
+72,737
+343% +$1.38M 0.02% 912
2019
Q4
$376K Buy
21,183
+10,701
+102% +$185K ﹤0.01% 2004
2019
Q3
$163K Buy
10,482
+1,986
+23% +$32.7K ﹤0.01% 2459
2019
Q2
$146K Sell
8,496
-32,285
-79% -$521K ﹤0.01% 2593
2019
Q1
$657K Buy
40,781
+25,532
+167% +$414K 0.01% 1598
2018
Q4
$223K Buy
+15,249
New +$243K ﹤0.01% 2331
2018
Q3
Sell
-8,066
Closed -$136K 3276
2018
Q2
$136K Buy
8,066
+16
+0.2% +$303 ﹤0.01% 2875
2018
Q1
$158K Buy
+8,050
New +$156K ﹤0.01% 2601
2017
Q4
Sell
-28,081
Closed -$488K 3376
2017
Q3
$488K Sell
28,081
-12,536
-31% -$170K ﹤0.01% 1868
2017
Q2
$521K Buy
40,617
+14,238
+54% +$190K ﹤0.01% 1837
2017
Q1
$342K Sell
26,379
-43,965
-63% -$556K ﹤0.01% 2098
2016
Q4
$695K Buy
70,344
+41,702
+146% +$457K 0.01% 1510
2016
Q3
$346K Buy
+28,642
New +$293K ﹤0.01% 2043
2016
Q2
Sell
-21,724
Closed -$206K 2769
2016
Q1
$206K Buy
+21,724
New +$204K ﹤0.01% 2182
2015
Q4
Sell
-21,360
Closed -$287K 2809
2015
Q3
$287K Buy
21,360
+14,343
+204% +$288K ﹤0.01% 1263
2015
Q2
$158K Sell
7,017
-10,949
-61% -$192K ﹤0.01% 2095
2015
Q1
$257K Buy
17,966
+690
+4% +$9.95K ﹤0.01% 1759
2014
Q4
$167K Buy
+17,276
New +$153K ﹤0.01% 2564
2014
Q2
Sell
-15,028
Closed -$191K 2593
2014
Q1
$191K Buy
+15,028
New +$223K ﹤0.01% 1951
2013
Q4
Sell
-21,947
Closed -$242K 2785
2013
Q3
$242K Buy
+21,947
New +$183K ﹤0.01% 2052

Other funds holding HALO

SG Americas Securities's HALO Position: Q2 2026 in Review

SG Americas Securities increased its Halozyme (HALO) stake by 1,322% in Q2 2026, buying an estimated $16.4M and bringing the position to 258,461 shares worth $20.2M. The position accounts for 0.01% of the portfolio, ranked #592.

SG Americas Securities first reported a position in HALO in Q3 2013 and has held it in 45 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • SG Americas Securities held 258,461 shares of Halozyme worth $20.2M as of Q2 2026.
  • SG Americas Securities bought 240,283 Halozyme shares in Q2 2026, an estimated $16.4M.
  • Halozyme made up 0.01% of SG Americas Securities's portfolio in Q2 2026, its #592 holding.
  • SG Americas Securities first reported a position in Halozyme in Q3 2013 and has held it in 45 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.